Home
Search
Schedule & Agenda

Braizon Therapeutics, Inc.

[Available On-Demand]
June 8-12, 2020
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies
Braizon is developing a drug delivery technology for crossing the Blood Brain Barrier via a Glucose Transporter using polymer nano-particle carriers. Our company objective is the application of revolutionary delivery technologies to improve the lives of people with unmet neurological needs.
Company Type:
Privately Funded Company
Company Website:
https://braizon.com/en/
Company HQ State:
Not Provided
Company HQ Country:
Japan
Year Founded:
2015
Main Therapeutic Focus:
CNS/Neurological
Lead Product in Development:
Undisclosed
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Philip Davy, PhD
Director of Business Development
Braizon Therapeutics, Inc.